2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study
Bajema K, Yan L, Li Y, Argraves S, Rajeevan N, Fox A, Vergun R, Berry K, Bui D, Huang Y, Lin H, Hynes D, Lucero-Obusan C, Schirmer P, Cunningham F, Huang G, Aslan M, Ioannou G. Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study. The Lancet Infectious Diseases 2025 PMID: 39848264, DOI: 10.1016/s1473-3099(24)00796-5.Peer-Reviewed Original ResearchRespiratory syncytial virusRespiratory syncytial virus vaccinePositive RSV testVaccine effectivenessRSV testCare encountersSecondary outcomesEmergency departmentRSV-associated hospitalisationsMedian follow-upUS Food and Drug AdministrationHealth-care useVeterans Health AdministrationRespiratory illness seasonMatched index dateElectronic health recordsLower respiratory tract diseaseRSV-related illnessFood and Drug AdministrationDepartment of Veterans Affairs Cooperative Studies ProgramVeterans Affairs Cooperative Studies ProgramCooperative Studies ProgramRSV infectionMedian ageUS Department
2021
Cooperative studies Program (CSP) #572: A study of serious mental illness in veterans as a pathway to personalized medicine in schizophrenia and bipolar illness
Harvey PD, Bigdeli TB, Fanous AH, Li Y, Rajeevan N, Sayward F, Radhakrishnan K, Huang G, Aslan M. Cooperative studies Program (CSP) #572: A study of serious mental illness in veterans as a pathway to personalized medicine in schizophrenia and bipolar illness. Personalized Medicine In Psychiatry 2021, 27: 100078. PMID: 34222732, PMCID: PMC8247126, DOI: 10.1016/j.pmip.2021.100078.Peer-Reviewed Original ResearchCooperative Studies ProgramFunctional deficitsSuicidal ideationNegative symptomsLifetime major depressive episodeMajor depressive episodeTreatment of symptomsSerious mental illnessPersonalization of treatmentFunctional capacity assessmentStructured diagnostic interviewVA Million Veteran ProgramDepressive episodeBipolar illnessMillion Veteran ProgramTreatment responseGeneral populationLifetime depressionPsychiatric treatmentRisk score analysisBipolar disorderFemale veteransMental illnessDiagnostic InterviewCognitive deficits